Cargando…
Radiolabeled Somatostatin Analogs—A Continuously Evolving Class of Radiopharmaceuticals
SIMPLE SUMMARY: Somatostatin receptors (SSTs) are of particular interest in oncology because these proteins are overexpressed on the cell membranes of different human malignancies, especially neuroendocrine tumors (NETs) and neuroendocrine neoplasms (NENs). Radiolabeled short peptide analogs of the...
Autores principales: | Fani, Melpomeni, Mansi, Rosalba, Nicolas, Guillaume P., Wild, Damian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909681/ https://www.ncbi.nlm.nih.gov/pubmed/35267479 http://dx.doi.org/10.3390/cancers14051172 |
Ejemplares similares
-
Evaluation of a New (177)Lu-Labeled Somatostatin Analog for the Treatment of Tumors Expressing Somatostatin Receptor Subtypes 2 and 5
por: Mansi, Rosalba, et al.
Publicado: (2020) -
A new (68)Ga-labeled somatostatin analog containing two iodo-amino acids for dual somatostatin receptor subtype 2 and 5 targeting
por: Mansi, Rosalba, et al.
Publicado: (2020) -
Overview of Radiolabeled Somatostatin Analogs for Cancer Imaging and Therapy
por: Eychenne, Romain, et al.
Publicado: (2020) -
Radiolabeled Bombesin Analogs
por: Mansi, Rosalba, et al.
Publicado: (2021) -
Metastatic Insulinoma Managed with Radiolabeled Somatostatin Analog
por: Costa, Ricardo, et al.
Publicado: (2013)